Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | PPM1B | O75688 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.41 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.39 |
| ▸ | KDM4A | O75164 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1333228 | 1.00 | ALDH1A1 (0.56) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| Ethylene Glycol SCHEMBL29002151 | 0.95 | ALDH1A1 (0.51) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL14674752 | 0.89 | ALDH1A1 (0.50) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| Succinic Acid SCHEMBL31137819 | 0.89 | CYP1A2 (0.47) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL30773222 | 0.87 | ALDH1A1 (0.49) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL1226562 | 0.86 | ALDH1A1 (0.54) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL17821007 | 0.86 | ALDH1A1 (0.47) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL846234 | 0.86 | ALDH1A1 (0.47) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL4069043 | 0.85 | CYP1A2 (0.44) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL8510382 | 0.81 | ALDH1A1 (0.53) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4580690-B1 | BIODEGRADABLE LUNG SEALANTS | ETHICON INC (US) | 2026-03-18 | — | — | EP | claimed |
| EP-4291256-B1 | TWO COMPONENT SEALING SYSTEMS INCLUDING SYNTHETIC MATRICES AND BIOSYNTHETIC ADHESIVES | ETHICON INC (US) | 2026-02-18 | — | — | EP | claimed |
| EP-3600189-B1 | SKIN CLOSURE SYSTEMS AND DEVICES OF IMPROVED FLEXIBILITY AND STRETCHABILITY FOR BENDABLE JOINTS | ETHICON INC (US) | 2026-02-18 | — | — | EP | claimed |
| US-12329853-B2 | Compositions and methods for treating ocular diseases | OCULAR THERAPEUTIX, INC. (US) | 2025-06-17 | — | — | US | claimed |
| US-12297335-B2 | Radiopaque multi-armed polymers and compositions, systems and methods pertaining to the same | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-05-13 | — | — | US | claimed |
| CN-118662684-B | Preparation method of biological antibacterial adhesive and application of obtained adhesive | 卓阮医疗科技（苏州）有限公司 | 2025-04-25 | — | — | CN | claimed |
| WO-2024215649-A1 | OCULAR IMPLANT COMPRISING AXITINIB POLYMORPH IV | OCULAR THERAPEUTIX, INC. (US) | 2024-10-17 | — | — | WO | claimed |
| EP-3515406-B1 | INTRACAMERAL DRUG DELIVERY DEPOTS | INCEPT LLC (US) | 2024-07-24 | — | — | EP | claimed |
| EP-4344745-A2 | SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE | Ocular Therapeutix, Inc. (US) | 2024-04-03 | — | — | EP | claimed |
| EP-3973952-B1 | SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE | OCULAR THERAPEUTIX INC (US) | 2024-02-14 | — | — | EP | claimed |
| EP-3518993-B1 | SCAFFOLDS WITH CHANNELS FOR JOINING LAYERS OF TISSUE AT DISCRETE POINTS | ETHICON INC (US) | 2020-10-28 | — | — | EP | claimed |
| CN-110461285-A | Skin closure system and device for improved flexibility and stretchability of a flexible joint | ETHICON INC | 2019-11-15 | — | — | CN | claimed |
| CN-105498559-B | Composite membrane based on functional protein | 中国科学院烟台海岸带研究所 | 2018-10-16 | — | — | CN | claimed |
| CN-105498559-A | Composite membrane based on functional protein | YANTAI INST COASTAL ZONE RES CAS | 2016-04-20 | — | — | CN | claimed |
| WO-2014053873-A1 | POLYMERIC PRODRUG CONJUGATES | Piramal Enterprises Limited (IN) | 2014-04-10 | — | — | WO | claimed |
| US-8617584-B2 | Adhesive tissue repair patch and collagen sheets | ANGIODEVICE INTERNATIONAL GMBH (CH) | 2013-12-31 | — | — | US | claimed |
| EP-2358412-B1 | AUTO-SEALANT MATRIX FOR TISSUE REPAIR | SOFRADIM PRODUCTION (FR) | 2012-07-11 | — | — | EP | claimed |
| EP-1935426-B1 | Prevention of biofilm formation using pegylated blood products | CANADIAN BLOOD SERVICES (CA) | 2012-04-18 | — | — | EP | claimed |
| US-20100233246-A1 | ADHESIVE TISSUE REPAIR PATCH AND COLLAGEN SHEETS | ANGIOTECH PHARMACEUTICALS (US), INC. (US) | 2010-09-16 | — | — | US | claimed |
| EP-0696617-B1 | Method of controlling structure stability of collagen fibers produced from solutions or dispersions treated with sodium hydroxide for infectious agent deactivation | COHESION TECH INC (US) | 2001-07-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12329853-B2 | Compositions and methods for treating ocular diseases | PDE6C, PDE6H, PDE6A | ALDH1A1 2175/4885KDM4E 3618/4885HPGD 461/4885 |
| US-20100233246-A1 | ADHESIVE TISSUE REPAIR PATCH AND COLLAGEN SHEETS | COL2A1, COL14A1, COL1A1 | ALDH1A1 4071/4885KDM4E 794/4885HPGD 2063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.